In the present study, we demonstrated that TAZ knockdown inhibited the migration of highly invasive triple-negative breast cancer cells (MDA-MB-231) by reducing the protein abundance of RhoA and Rho-dependent kinases, particularly LIMK1 and MLCK. The gene discussed is RHOA; the disease is triple-negative breast carcinoma.